Nexvet Announces Initiation of Pivotal Efficacy Study of Frunevetmab in Cats
Posted:
2016-12-12 in Press Releases
Osprey Introduces DyeVert PLUS at TCT
Posted:
2016-11-02 in Press Releases
Osprey Medical Inc. Releases Q3 2016 Cash Flow Results
Posted:
2016-10-14 in Press Releases
Elastagen Awarded $4m via NSW Government's Medical Devices Fund
Posted:
2016-10-11 in Press Releases
Global Kinetics Corporation Announces New President and CEO
Posted:
2016-08-30 in Press Releases
Osprey Medical Announces Oversubscribed A$28 Million Private Placement
Posted:
2016-08-04 in Press Releases
Osprey Medical Inc. Quarterly Cash Flow Report July '16
Posted:
2016-07-20 in Press Releases
Key Sales Milestones
Posted:
2016-07-07 in Press Releases
DyeVert Pilot Trial Results Presented at EuroPCR
Posted:
2016-05-20 in Press Releases
Heart Metabolics Adds New Board Member and Expands Senior Management Team
Posted:
2016-05-17 in Press Releases
AVERT Trial Results Presented at SCAI
Posted:
2016-05-09 in Press Releases
Signostics Receives FDA Clearance for Uscan™
Posted:
2016-05-06 in Press Releases
Nexvet and Zenoaq Announce PD-1 mAb Candidate for Canine Cancer
Posted:
2016-05-03 in Press Releases
$4m start-up investment to accelerate drug discovery
Posted:
2016-03-23 in Press Releases
Heart Metabolics Announces Multiple Senior Appointments to Management Team
Posted:
2016-03-15 in Press Releases
Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2016
Posted:
2016-02-16 in Press Releases
Osprey Medical Receives FDA Clearance for Key DyeVert™ System Claims
Posted:
2016-02-08 in Press Releases
Osprey Medical Inc. Quarterly Cash Flow Report
Posted:
2016-01-28 in Press Releases
Elastagen Completes A$13m Series B Equity Financing
Posted:
2016-01-07 in Press Releases